The DIVB ETF is rated a Buy due to its superior risk-adjusted returns and balanced approach combining dividends and share buybacks, avoiding heavy concentration in mega-cap stocks. Since inception, DIVB has delivered a 14.35% annualized return, outperforming SCHD's 12.14%. Key risks include potential payout cuts from top holdings like Accenture and IBM, and market shifts toward defensive sectors. A critical re-evaluation of DIVB is scheduled for June 2027.
As of Oct 10, 2026 20:41 WIB, SCHD trades at USD 33.04 with a slight 1-day decline of 0.33%, while Accenture (ACN), a key holding mentioned as a risk factor, is priced at USD 209.06 and shows a modest 0.34% gain. On Pluang, SCHD sees a dominant 88% buy order activity, reflecting strong investor interest despite the minor dip. The article highlights DIVB's superior returns, contrasting with SCHD's current market price and trading dynamics on Pluang.
The S&P 500 remains resilient, just 3.5% below its all-time highs, showing a solid 10% gain year-to-date despite recent volatility driven by tech sector cash flow concerns. Q3 earnings per share growth is robust at 30%, and market breadth is improvin...
The Schwab US Dividend Equity ETF (SCHD) is recommended as a Buy for the next 12 to 24 months due to consistent dividend growth and robust portfolio diversification. Its healthcare sector allocation has increased to nearly 19%, making it a key driver...
The Schwab US Dividend Equity ETF (SCHD) is recommended as a strong buy due to its focus on high-quality dividends, lower exposure to volatile technology sectors, and stable cash flows. This makes it a defensive choice for retirees and cautious incom...
